114 related articles for article (PubMed ID: 1079317)
1. Letter: Methotrexate-citrovorum factor in treating osteogenic sarcoma.
Djerassi I
N Engl J Med; 1975 May; 292(21):1133-4. PubMed ID: 1079317
[No Abstract] [Full Text] [Related]
2. [High-dose methotrexate with citrovorum factor rescue in osteogenic carcinoma].
Levi M; Sulkes A; Katz E; Rizel S; Biran S
Harefuah; 1980 Sep; 99(5-6):110-3. PubMed ID: 6970707
[No Abstract] [Full Text] [Related]
3. High-dose methotrexate with citrovorum factor in osteogenic sarcoma--progress report II.
Jaffe N; Frei E; Traggis D; Cassady JR; Watts H; Filler RM
Cancer Treat Rep; 1977 Jul; 61(4):675-9. PubMed ID: 301780
[TBL] [Abstract][Full Text] [Related]
4. "Single"-agent activity of high-dose methotrexate with citrovorum factor rescue.
Von Hoff DD; Rozencweig M; Louie AC; Bender RA; Muggia FM
Cancer Treat Rep; 1978 Feb; 62(2):233-5. PubMed ID: 305823
[No Abstract] [Full Text] [Related]
5. Osteogenic sarcoma: state of the art with high-dose methotrexate treatment.
Jaffe N
Clin Orthop Relat Res; 1976 Oct; (120):95-102. PubMed ID: 1086179
[TBL] [Abstract][Full Text] [Related]
6. Progress report on high-dose methotrexate (NSC-740) with citrovorum rescue in the treatment of metastatic bone tumors.
Jaffe N
Cancer Chemother Rep; 1974; 58(2):275-80. PubMed ID: 4598245
[No Abstract] [Full Text] [Related]
7. Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma.
Jaffe N; Frei E; Traggis D; Bishop Y
N Engl J Med; 1974 Nov; 291(19):994-7. PubMed ID: 4606174
[No Abstract] [Full Text] [Related]
8. High-dose methotrexate with citrovorum factor rescue and adriamycin in childhood osteogenic sarcoma.
Rosen G; Suwansirikul S; Kwon C; Tan C; Wu SJ; Beattie EJ; Murphy ML
Cancer; 1974 Apr; 33(4):1151-63. PubMed ID: 4544836
[No Abstract] [Full Text] [Related]
9. High-dose methotrexate in osteogenic sarcoma: a 5-year experience.
Jaffe N; Frei E; Watts H; Traggis D
Cancer Treat Rep; 1978 Feb; 62(2):259-64. PubMed ID: 346215
[No Abstract] [Full Text] [Related]
10. Patient case involving high-dose methotrexate followed by leucovorin rescue.
Alsop JA
Am J Hosp Pharm; 1978 Feb; 35(2):127. PubMed ID: 305201
[No Abstract] [Full Text] [Related]
11. [Management of the administration of leucovorin calcium in high-dose methotrexate therapy].
Kickinger W; Ritschl P; Kotz R
Arzneimittelforschung; 1989 Jun; 39(6):728-31. PubMed ID: 2789050
[TBL] [Abstract][Full Text] [Related]
12. High-dose methotrexate for the patient with osteogenic sarcoma.
Nirenberg A
Am J Nurs; 1976 Nov; 76(11):1776-80. PubMed ID: 136192
[No Abstract] [Full Text] [Related]
13. [H-MTX-CF treatment and osteogenic sarcoma (author's transl)].
Goto M
Hokkaido Igaku Zasshi; 1981 Mar; 56(2):235. PubMed ID: 6976923
[No Abstract] [Full Text] [Related]
14. Letter: Limitations of methotrexate and citrovorum-factor treatment.
Frei E; Jaffe NJ; Pitman S
N Engl J Med; 1975 Jan; 292(2):107-8. PubMed ID: 1078551
[No Abstract] [Full Text] [Related]
15. High-dose methotrexate therapy with citrovorum factor: a pharmacologic perspective in murine tumor models.
Sirotnak FM; Donsbach RC; Dorick DM; Moccio DM
Cancer Treat Rep; 1977 Jul; 61(4):565-74. PubMed ID: 301778
[No Abstract] [Full Text] [Related]
16. High-dose methotrexate with citrovorum factor rescue: predictive value of serum methotrexate concentrations and corrective measures to avert toxicity.
Nirenberg A; Mosende C; Mehta BM; Gisolfi AL; Rosen G
Cancer Treat Rep; 1977 Aug; 61(5):779-83. PubMed ID: 302143
[No Abstract] [Full Text] [Related]
17. Transient cerebral dysfunction following chemotherapy for osteogenic sarcoma.
Allen JC; Rosen G
Ann Neurol; 1978 May; 3(5):441-4. PubMed ID: 310278
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy for osteogenic sarcoma: an investigative method, not a recipe.
Rosen G; Nirenberg A
Cancer Treat Rep; 1982 Sep; 66(9):1687-97. PubMed ID: 6981454
[No Abstract] [Full Text] [Related]
19. Prognostic factors in the response of primary osteogenic sarcoma to preoperative chemotherapy (high-dose methotrexate with citrovorum factor).
Juergens H; Kosloff C; Nirenberg A; Mehta BM; Huvos AG; Rosen G
Natl Cancer Inst Monogr; 1981 Apr; (56):221-6. PubMed ID: 6975439
[TBL] [Abstract][Full Text] [Related]
20. The role of high-dose methotrexate with citrovorum factor "rescue" in the treatment of osteogenic sarcoma.
Jaffe N; Traggis D; Cassady JR; Filler RM; Watts H; Frei E
Int J Radiat Oncol Biol Phys; 1977; 2(3-4):261-6. PubMed ID: 301137
[No Abstract] [Full Text] [Related]
[Next] [New Search]